Diabetes

Fat degrading enzyme implicated in type 2 diabetes

Investigators at Karolinska Institutet have identified a potential therapeutic target for treatment of obesity-associated metabolic diseases such as type 2 diabetes and nonalcoholic hepatic steatosis. The work, performed ...

Jan 18, 2017
popularity0 comments 0